Thursday, July 14, 2022

Gene Editing Drug (first clinical trial)

Cardiovascular diseases are the leading cause of death in the world, causing approximately 18 million deaths every year. Nature news reports that the first phase 1 clinical trials have now begun for a gene-editing drug for high cholesterol, designed to modify the gene which regulates cholesterol in the bloodstream. This is a pivotal stage in the rapidly unfolding “genetic revolution” of the past half a century.